Try our Advanced Search for more refined results

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. August 22, 2023

    Walmart's Opioid Deal Advances With States' Participation

    Walmart revealed in a regulatory filing late Tuesday that it will pay about $2.8 billion of the roughly $3 billion deal it struck to end thousands of lawsuits accusing its nationwide pharmacy network of fueling America's opioid crisis, after an administrator determined enough municipalities have joined the state settlements.

  2. July 14, 2023

    DEA Must Produce Data For Opioid MDL Trials, Judge Rules

    The Ohio federal judge steering multidistrict litigation over the opioid crisis on Friday signed off on a subpoena requesting information on national opioid sales from the U.S. Drug Enforcement Administration, saying the data's importance to the litigation "cannot be overstated."

  3. June 15, 2023

    Hospitals Seek Class Counsel In Opioid MDL

    Hospitals have asked the Ohio federal judge overseeing opioid multidistrict litigation to name Don Barrett of Barrett Law Group as interim class counsel, saying their claims are distinct from those brought by local governments and his appointment would aid settlement talks.

  4. May 17, 2023

    Walgreens To Pay SF $230M After Landmark Opioid Trial Loss

    Walgreens Co. has agreed to pay $230 million to San Francisco for its role in the city's opioid epidemic following a landmark weeks-long bench trial last year that found the pharmacy chain liable for distributing thousands of suspicious painkiller prescriptions in the area without proper screenings, the city announced Wednesday.

  5. May 02, 2023

    Reject 'Carte Blanche' For Risky Opioid Sales, 4th Circ. Urged

    A West Virginia city and county have told the Fourth Circuit that distributors of addictive painkillers misinterpreted state nuisance law and the federal Controlled Substances Act when seeking to uphold a lower court's dismissal of the local governments' multibillion-dollar opioid lawsuit.

  6. April 24, 2023

    Opioid Judge Rips UnitedHealth's 'Insulting' Coercion Charge

    The top federal judge in multidistrict opioid litigation lashed out Monday against new accusations of using his gavel as a cudgel to bully corporations into settlements, calling the criticism from a major division of UnitedHealth Group Inc. "meritless" and "insulting."

  7. April 11, 2023

    Mich. County, Atty Sanctioned For Opioid Deal Challenge

    A Michigan state judge on Tuesday sanctioned Ottawa County and its outside counsel for filing what she called a frivolous lawsuit challenging a national opioid settlement, ruling the county had an unreasonable interpretation of the deal and that its lawyer lied about who was overseeing the funds.

  8. March 24, 2023

    Opioid Theory Reaches 'Alcohol, Guns, Phones,' 4th Circ. Told

    A West Virginia federal judge's monumental rejection of a multibillion-dollar opioid case correctly avoided a "dramatic rewriting" of state law that would threaten legal exposure for sellers of liquor, cellphones, firearms and other lawful products, drug distributors told the Fourth Circuit on Friday.

  9. March 08, 2023

    Opioid Judge Eyes New Bellwethers Amid 'Unwieldy' Delays

    The Ohio federal judge guiding multidistrict opioid litigation is opening new bellwether frontiers involving pharmacy chains and health insurance entities that have sat on the MDL's sidelines, and he signaled impatience this week with "an inefficient use of judicial resources" amid lengthy settlement talks.

  10. March 01, 2023

    Distributors Win Milestone Trial Over Individual Opioid Abuse

    Pharmaceutical wholesalers aren't responsible for harms to individuals whose family members abused narcotics, a Georgia jury decided Wednesday, capping off a first-of-its-kind trial that threatened to open a massive new front in opioid litigation despite multibillion-dollar settlements covering harms suffered by communities.